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Conclusions: This study demonstrates that Ll_ differentially effects the correlation 
between the functional assessment (FFR) and the “anatomical’ angiographic assess- 
ment (%DS) of coronary lesions and suggests that, l-l_ has a significant impact on the 
physiologic significance of coronary artery lesions. 
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0029-l Impact of Lesion Length on Vascular Brachytherapy 
Failure: A Comparison of Bets (b) versus Gamma (g) 
Irradiation In 99tl Patients 
BShirai, Alexandra J. Lansky, Roxana Mehran. Kartik Desai, Costantino 
Costantini-Ottiz, Brian Proctor, Teraza Conway, Martin Fahy, Maria Corral, Christina 
Brestowski, George Dangas, Gregg W. Stone, Paul Teirstein, Jeffrey Moses, Marlin B. 
Leon, Cardiovascular Research Foundation, New York. 
Background: Lesion length has been an important predictor of restenosis (RS) among 
pts treated with vascular brachytherapy (VET). Methods: We compared the impact of 
lesion length on RS in 990 pts treated with VBT (370 Gamma; 265 Beta; 355 placebo) for 
treatment of native coronary ISR. Results: Lesion length was an independent predictor of 
treated segment RS (OR=1.043, p~O.0001) but not stent edge RS (p=O.lZl). Regression 
analysis was used to construct probability models for ‘treated segment’ RS (including 
edges) (fig 1). ‘in-stent’ (fig 2) and “stent edge” (Fig 3) RS based on lesion lengths. A 
consistent pronounced treatment effect was observed with Gamma VBT at all lesion 
lengths. Beta VBT demonstrated the lowest probability of ‘“in-stent” RS at all lesion 
lengths. The divergent probability of ‘in-stent” and ‘treated segment” RS observed with 
beta radiation of focal lesions is a direct result of the higher frequency of stent edge RS 
as lesion length decreases. Conclusions: Mechanisms of edge RS differ for Beta and 
Gamma VBT. Edge RS appears to increase with increasing lesion length after Gamma 
VBT, possibly suggesting lack of adequate lesion coverage. With beta VBT, increasing 
edge RS among shorter lesions, may represent a proliferative response resulting from 
exposure of healthy arterial segments to VBT or to the steep dose fall-off zones. 
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0029-2 Geographic Miss Is Not Associated With Restenosis or 
the Edge Phenomenon in the INHIBIT Trial 
0. Costantini, Alexandra J. Lansky, Kartik Desai, Roxana Mehran, Kazuyuki 
Shirai, Ecatarfna Cristea, Horia Marginean, George Dangas. Gregg W. Stone, Marlin B. 
Leon, Cardiovascular Research Foundation. New York. 
Background: “Geographic Miss” (GM) has been implicated as one impoltant cause 
explaining the preponderance of “edge” restenosis observed after vascular brschyther- 
apy. Methods: To determlne the impact of GM in INHIBIT, GM (length (mm) of balloon 
injuty beyond the proximal or distal radiated edges) was systematically measured in all 
patients using QCA (MEDIS). The probability of restenosis based on the length of GM 
was assessed for placebo and radiated pts using regression analysis, and the frequency 
of edge restenosis was compared among radiated patients with and without GM. 
Results: The frequency of GM (19.9% “s 15.3%, p&38) and the total length of GM 
(3.66mm vs 4.69mm, p=O.17) were similar in radiated and placebo pts respectively. The 
probability of restenosis for placebo and radiated pts was not affected by the presence or 
extent of GM and the relative benefit of P-32 radiation was maintained independent of 
GM (figure). Among radiated pts with GM (N=31) and without GM (N=125). there was no 
significant difference in restenosis (22.7% vs 25.7%, p=NS), proximal dose fall-off zone 
% stenosis (16% vs 21%. p=NS) or distal dose fall-off zone % stenosis (26% vs 23%. 
p=NS). Conclusion: In the INHIBIT trial, the presence and length of GM was not associ- 
ated with increases in overall restenosis for either radiated or placebo patients and the 
treatment effect of P-32 radiation was maintained despite the presence of GM. 
2:00 p.m. 
0029-3 Excessive Beta-Radiation Exposure to the Non-Target 
Segment: An Intravascular Ultrasound Doslmetric 
Analysis 
anedp. Yasuhiro Honda, Yoshihiro Merino, Atsushi Takagi, Ali H. Hassan, Tim 
Fox, Ian Crccker, Alexandra J. lansky, Paul G. Ycck, Raoul Bonan, Peter J. Fitzgerald, 
Stanford University, Stanford, California, Montreal Heart Institute, Montreal, Canada. 
Background: Recently, longer radioactive seed trains have been introduced into cathe- 
ter-based intracoronary brachytherapy to cover the entire target segment to avoid “geo- 
graphic miss’ and edge effects. This strategy, however, potentially leads to a higher 
radiation exposure to distal normal vasculature due to the natural tapering in distal core- 
nary arteries. The aim of this study was to evaluate the effect of beta-radiation on non- 
Injured distal segments using IVUS-based dosimetric analysis. 
Methods: We analyzed 16 instent restenosis cases (stent length: 20+6 mm) treated with 
a 40-mm scSrlY source train. The prescribed dose was 16 Gy (reference $3.35 mm) or 
20 Gy (reference > 3.35 mm) at 2 mm from the source. Non-injured but fully irradiated 
distal references were determined by angiography (average distance from stent edge: 
7.0 mm). Serial IVUS (baseline and 6-month follow-up (FU)) was performed with auto- 
mated pullback at 0.5 mm/s. Based upon the three-dtmensional vessel contours obtained 
at baseline, dose analysis was performed to calculate the minimum dose actually deliv- 
ered to 90% of plaque volume using a cumulative curve of dose-volume histogram 
(DVsc). Morphometric parameters (vessel, plaque, and lumen volumes) and DV, were 
computed in every 2.mm subsegment (n=49). Percent volume changes were calculated 
as (FU-baseline)/baseline. 
Results: There was a significant positive correlation between the delivered dose (DVs,,) 
and increase in plaque area during FU (p=O.O06). However, DVw also correlated posi- 
tively with change in vessel area (p=O.OOS), representing positive vessel remodeling fol- 
lowing beta-radiation. Consequently, no significant relationship was seen between DV,, 
and lumen change. 
Conclusions: Detailed IVUS-based dosimetric analysis demonstrated that beta-radia- 
tion promoted positive remodeling, preventing lumen loss despite an increase in plaque 
mass. The treatment of in-stent restenosis with long radioactive seed trains appeared to 
be safe with no deleterious effect on non-injured distal segments at the first 6 months. 
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0029-4 lntracoronary Beta-Radiotherapy With 32P for the 
Prevention of Restenosls in Small Versus Large Vessels 
m Nauven - I HQ Pawel T. Zymek, Grzegorz L. Kaluza, Albert E. Raizner, for the 
PREVENT Investigators. The Methodist DeBakey Heart Center, Houston, Texas, Baylor 
Co//ege of Medicine, Houston, Texas. 
Background: Small vessel diameter (reference diameter ~3.0 mm) is predictive of rest- 
enosis in patients undergoing percutaneous coronary interventions. The Proliferation 
Reduction With Vascular Energy Trial (PREVENT) demonstrated that intracoronaly p- 
radiotherapy (ICR) with s*P is effective in inhibiting restenosis. We sought to determine 
the relative efficacy of ICR in vessels ~3.0 mm and 23.0 mm in 165 patients treated 
according to the PREVENT protocol. 
Methods and Results: The ICR-treated patients (11~125) were compared to sham- 
treated (control) patients (n=40) and analyzed according to the reference vessel diame- 
ter. The angiographic indices of restenosis are presented in the table (T=target site, 
T+A=target site plus adjacent edges: comparisons are ICR vs. control. ‘p<O.O03, 
“PCO.03). 
No. of patients 
Acute gain (mm) 
Late lumen loss (mm) 
Late loss index (%) 
Restenosis rate, T (%) 
c3.0 mm 23.0 mm 
ICR Control ICR Control 
46 21 77 19 
1.59fl.41 1.74*0.31 2.24i0.53 2.07iO.46 
0.22M.90 0.96fl.61 0.27*0.59* 1.05*0.76 
12*59 54+34 1 x29’ 5ti32 
18” 46 6’ 37 
Restenosis rate, T+A (%) 46 55 19 37 
